Philip NUNN

City:

Mountain View, California

Country:

United States

Published Applications:

Last publication date:

2025-07-10

Top Assignees for applications by Philip NUNN

The entities that hold a legal rights for patent applications filed by inventor NUNN Philip:

Principia Biopharma Inc. 2 Bridgewater, NJ United States

Recent patent applications by NUNN Philip

Philip NUNN from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-10

US20250221999A1

Human necessities

Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile

#2 | 2023-04-20

US20230124267A1

Human necessities

Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

#3 | 2021-07-08

US20210205312A1

Human necessities

TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR 2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE

#4 | 2021-04-15

US20210106584A1

Human necessities

METHODS FOR TREATING IMMUNE THROMBOCYTOPENIA BY ADMINISTERING (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE

#5 | 2018-01-18

US20180015088A1

Human necessities

SITE SPECIFIC DOSING OF A BTK INHIBITOR

InventorID:

2091145 ⎘